Unusual 11 Mid-Day Movers 11/18: IDMI, PSUN, DHT, CQB Higher; XTLB, NCOC, SKS, DIVX Lower
Tweet Send to a Friend
XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB) 94% LOWER; announced today the top-line results from the Bicifadine Phase 2b clinical trial for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
